Is Clinica Baviera SA halal to invest in?

According to Musaffa's Shariah screening methodology, Clinica Baviera SA (CBAV.MC) is currently classified as HALAL as of December 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Clinica Baviera SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Clinica Baviera SA using these criteria to determine its compliance status.

Can Muslims buy shares of Clinica Baviera SA?

Muslim investors may consider investing in Clinica Baviera SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Clinica Baviera SA classified as HALAL?

Musaffa determines the Shariah status of Clinica Baviera SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Clinica Baviera SA updated?

The Shariah compliance status of Clinica Baviera SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Clinica Baviera SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Clinica Baviera SA?

You can check the latest Shariah compliance status of Clinica Baviera SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

CBAV.MC Shariah Compliance

Screening Methodology: AAOIFI

UNLOCK FOR FREE

Last Updated: December 17, 2025

Report Source: 2025 2nd Quarter Report

Analyst's Ratings for Clinica Baviera SA (CBAV.MC)

Based on 7 analysts giving stock ratings to Clinica Baviera SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Clinica Baviera SA. Stock Analysis CBAV.MC

Spain Health Care Small Cap Report: Q2, 2025

Clínica Baviera SA is engaged in the provision of diagnosis and treatment for eye disorders. The company is headquartered in Madrid, Madrid and currently employs 1,751 full-time employees. The company went IPO on 2000-01-01. The firm focuses on providing services within the field of ophthalmic medicine. The firm is specialized in the diagnosis and treatment of eye disorders, including myopia, hyperopia, astigmatism, cataracts, glaucoma, vitreous-retina and strabismus, among others. The firm operates a network of clinics located in various European countries, such as Spain, Germany, Austria and Italy. The firm is a parent of the Baviera Group, a group that comprises a number of controlled entities, including Clinica Baviera Italia Srl, Clinica Baviera Mallorca SL, Care Vision Germany GmbH and Castellana de Intermediacion Sanitaria SL, among others.

Key Statistics of Clinica Baviera SA (CBAV.MC)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€47.00€49.30

Today's Open

€48.00

Volume

7693.00

P/E Ratio (TTM)

19.95

52 Week Range

€29.70€56.60

Market Cap

873.87M

Avg. Volume

2022.65

Dividend Yield

3.29%

Financial Metrics & Statements of Clinica Baviera SA (CBAV.MC)

Community-Curated Collections with Clinica Baviera SA (CBAV.MC) ( With CBAV.MC )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

High Dividend Halal Stocks in Spain

By Investment Alchemist

2 Followers

+7 more

Top Stocks in the Healthcare Sector in Spain